VERACYTE
VCYT Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-04
2025-06-06
LEITE JOHN
Chief Commercial Officer-CLIA
S - Sale
Common Stock
-2,809
$27.00
-75,843
1
$2.1B
2025-06-02
2025-06-04
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-5,370
$27.00
-145K
1
$2.1B
2025-06-02
2025-06-04
FEBBO PHILLIP
Chief Scientific & Med Officer
F - Tax
Common Stock
-2,955
$27.00
-79,785
1
$2.1B
2025-06-02
2025-06-04
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-2,900
$27.00
-78,300
1
$2.1B
2025-06-02
2025-06-04
MCGUIRE ANNIE
SVP, General Counsel
F - Tax
Common Stock
-3,505
$27.00
-94,635
1
$2.1B
2025-06-02
2025-06-04
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-9,399
$27.00
-254K
1
$2.1B
2025-06-02
2025-06-04
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-1,848
$27.00
-49,896
1
$2.1B
2025-03-07
2025-03-10
LEITE JOHN
Chief Commercial Officer-CLIA
S - Sale
Common Stock
-7,411
$32.00
-237K
2
$2.1B
2025-03-06
2025-03-10
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
30,200
$0.00
1
$2.1B
2025-03-06
2025-03-10
FEBBO PHILLIP
Chief Scientific & Med Officer
A - Grant
Common Stock
24,160
$0.00
1
$2.1B
2025-03-06
2025-03-10
LEITE JOHN
Chief Commercial Officer-CLIA
A - Grant
Common Stock
36,240
$0.00
1
$2.1B
2025-03-06
2025-03-10
WYGANT JONATHAN
VP, Chief Accounting Officer
A - Grant
Common Stock
13,288
$0.00
1
$2.1B
2025-03-04
2025-03-06
STAPLEY MARC
Chief Executive Officer
S - Sale
Common Stock
-52,697
$33.00
-1.74M
3
$2.1B
2025-03-04
2025-03-06
FEBBO PHILLIP
Chief Scientific & Med Officer
S - Sale
Common Stock
-8,037
$33.00
-265K
2
$2.1B
2025-03-04
2025-03-06
MCGUIRE ANNIE
SVP, General Counsel
S - Sale
Common Stock
-1,142
$34.00
-38,828
1
$2.1B
2025-03-02
2025-03-03
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-11,070
$35.00
-387K
1
$2.1B
2025-03-02
2025-03-03
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-7,650
$35.00
-268K
1
$2.1B
2025-03-02
2025-03-03
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-20,324
$35.00
-711K
1
$2.1B
2025-03-02
2025-03-03
FEBBO PHILLIP
Chief Scientific & Med Officer
F - Tax
Common Stock
-6,754
$35.00
-236K
1
$2.1B
2025-03-02
2025-03-03
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-4,301
$35.00
-151K
1
$2.1B
2025-02-27
2025-03-03
LEITE JOHN
Chief Commercial Officer-CLIA
S - Sale
Common Stock
-5,746
$34.00
-195K
1
$2.1B
2025-02-27
2025-03-03
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-34,273
$34.00
-1.17M
1
$2.1B
2025-02-27
2025-03-03
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
23,170
$0.00
1
$2.1B
2025-02-27
2025-03-03
FEBBO PHILLIP
Chief Scientific & Med Officer
A - Grant
Common Stock
30,589
$0.00
1
$2.1B
2025-02-27
2025-03-03
LEITE JOHN
Chief Commercial Officer-CLIA
A - Grant
Common Stock
11,006
$0.00
1
$2.1B
2025-02-27
2025-03-03
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
23,170
$0.00
1
$2.1B
2025-02-27
2025-03-03
LEITE JOHN
Chief Commercial Officer-CLIA
A - Grant
Common Stock
11,006
$0.00
1
$2.1B
2025-02-27
2025-03-03
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-11,911
$34.00
-405K
1
$2.1B
2025-02-27
2025-03-03
FEBBO PHILLIP
Chief Scientific & Med Officer
F - Tax
Common Stock
-15,672
$34.00
-533K
1
$2.1B
2025-02-27
2025-03-03
LEITE JOHN
Chief Commercial Officer-CLIA
S - Sale
Common Stock
-5,746
$34.00
-195K
1
$2.1B
2025-02-27
2025-03-03
FEBBO PHILLIP
Chief Scientific & Med Officer
A - Grant
Common Stock
30,589
$0.00
1
$2.1B
2025-02-27
2025-03-03
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-11,911
$34.00
-405K
1
$2.1B
2025-02-27
2025-03-03
FEBBO PHILLIP
Chief Scientific & Med Officer
F - Tax
Common Stock
-15,672
$34.00
-533K
1
$2.1B
2025-02-27
2025-03-03
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-34,273
$34.00
-1.17M
1
$2.1B
2025-02-03
2025-02-05
CHAMBERS REBECCA
Chief Financial Officer
S - Sale
Common Stock
-527
$44.00
-23,188
1
$2.1B
2024-12-13
2024-12-17
STAPLEY MARC
Chief Executive Officer
S - Sale
Common Stock
-5,590
$43.00
-240K
2
$2.1B
2024-12-04
2024-12-06
MCGUIRE ANNIE
SVP, General Counsel
S - Sale
Common Stock
-18,699
$44.00
-823K
1
$2.1B
2024-12-04
2024-12-06
FEBBO PHILLIP
Chief Scientific & Med Officer
S - Sale
Common Stock
-3,934
$44.00
-173K
1
$2.1B
2024-12-04
2024-12-05
FEBBO PHILLIP
Chief Scientific & Med Officer
S - Sale
-1,311
$44.00
-57,684
1
$2.1B
2024-12-03
2024-12-04
LEITE JOHN
Chief Commercial Officer-CLIA
S - Sale
Common Stock
-1,050
$43.00
-45,150
1
$2.1B
2024-12-03
2024-12-04
CHAMBERS REBECCA
Chief Financial Officer
S - Sale
Common Stock
-7,000
$43.00
-301K
1
$2.1B
2024-12-03
2024-12-04
WYGANT JONATHAN
VP, Chief Accounting Officer
S - Sale
Common Stock
-956
$43.00
-41,108
1
$2.1B
2024-12-02
2024-12-04
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-1,314
$44.00
-57,816
1
$2.1B
2024-12-02
2024-12-04
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-3,464
$44.00
-152K
1
$2.1B
2024-12-02
2024-12-04
FEBBO PHILLIP
Chief Scientific & Med Officer
F - Tax
Common Stock
-6,738
$44.00
-296K
1
$2.1B
2024-12-02
2024-12-04
MCGUIRE ANNIE
SVP, General Counsel
F - Tax
Common Stock
-1,918
$44.00
-84,392
1
$2.1B
2024-12-02
2024-12-04
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-5,748
$44.00
-253K
1
$2.1B
2024-12-02
2024-12-04
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-1,087
$44.00
-47,828
1
$2.1B
2024-11-27
2024-11-29
WYGANT JONATHAN
VP, Chief Accounting Officer
S - Sale
Common Stock
-5,032
$43.00
-216K
1
$2.1B
2024-11-12
2024-11-14
CHAMBERS REBECCA
Chief Financial Officer
S - Sale
Common Stock
-15,275
$38.00
-580K
1
$2.1B
2024-09-04
2024-09-06
LEITE JOHN
Chief Commercial Officer-CLIA
S - Sale
Common Stock
-5,479
$30.00
-164K
1
$2.1B
2024-09-02
2024-09-04
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-5,748
$32.00
-184K
1
$2.1B
2024-09-02
2024-09-04
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-1,087
$32.00
-34,784
1
$2.1B
2024-09-02
2024-09-04
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-3,464
$32.00
-111K
1
$2.1B
2024-09-02
2024-09-04
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-1,315
$32.00
-42,080
1
$2.1B
2024-09-02
2024-09-04
MCGUIRE ANNIE
SVP, General Counsel
F - Tax
Common Stock
-1,920
$32.00
-61,440
1
$2.1B
2024-07-16
2024-07-18
LEITE JOHN
Chief Commercial Officer-CLIA
S - Sale
Common Stock
-1,277
$25.00
-31,925
1
$2.1B
2024-06-02
2024-06-04
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-3,462
$21.00
-72,702
1
$2.1B
2024-06-02
2024-06-04
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-1,314
$21.00
-27,594
1
$2.1B
2024-06-02
2024-06-04
MCGUIRE ANNIE
SVP, General Counsel
F - Tax
Common Stock
-1,919
$21.00
-40,299
1
$2.1B
2024-06-02
2024-06-04
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-5,746
$21.00
-121K
1
$2.1B
2024-06-02
2024-06-04
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-1,087
$21.00
-22,827
1
$2.1B
2024-04-01
2024-04-02
EASTHAM KARIN
M - Exercise
Stock Option (right to buy)
-10,000
$13.00
-130K
1
$2.1B
2024-03-15
2024-03-19
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
4,318
$0.00
1
$2.1B
2024-03-15
2024-03-19
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-2,189
$21.00
-45,969
1
$2.1B
2024-03-15
2024-03-19
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-5,971
$21.00
-125K
1
$2.1B
2024-03-06
2024-03-08
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
59,856
$0.00
1
$2.1B
2024-03-06
2024-03-08
FEBBO PHILLIP
Chief Scientific & Med Officer
A - Grant
Common Stock
39,904
$0.00
1
$2.1B
2024-03-06
2024-03-08
LEITE JOHN
Chief Commercial Officer-CLIA
A - Grant
Common Stock
49,880
$0.00
1
$2.1B
2024-03-06
2024-03-08
WYGANT JONATHAN
VP, Chief Accounting Officer
A - Grant
Common Stock
23,942
$0.00
1
$2.1B
2024-03-02
2024-03-05
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-13,286
$24.00
-319K
1
$2.1B
2024-03-02
2024-03-05
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-2,337
$24.00
-56,088
1
$2.1B
2024-03-02
2024-03-05
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-6,112
$24.00
-147K
1
$2.1B
2024-03-02
2024-03-05
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-3,008
$24.00
-72,192
1
$2.1B
2024-03-01
2024-03-05
JONES EVAN/ FA
M - Exercise
Stock Option (right to buy)
-10,000
$13.00
-130K
1
$2.1B
2023-12-02
2023-12-05
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-1,800
$27.00
-48,600
1
$2.1B
2023-12-02
2023-12-05
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-556
$27.00
-15,012
1
$2.1B
2023-12-02
2023-12-05
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-3,203
$27.00
-86,481
1
$2.1B
2023-12-02
2023-12-05
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-507
$27.00
-13,689
1
$2.1B
2023-10-02
2023-10-04
FEBBO PHILLIP
Chief Scientific & Med Officer
A - Grant
Stock Option (right to buy)
85,858
$0.00
1
$2.1B
2023-10-02
2023-10-04
FEBBO PHILLIP
Chief Scientific & Med Officer
A - Grant
Common Stock
53,182
$0.00
1
$2.1B
2023-09-02
2023-09-06
LEITE JOHN
Chief Commercial Officer-CLIA
F - Tax
Common Stock
-2,222
$27.00
-59,994
1
$2.1B
2023-09-02
2023-09-06
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-3,652
$27.00
-98,604
1
$2.1B
2023-09-02
2023-09-06
MCGUIRE ANNIE
SVP, General Counsel
F - Tax
Common Stock
-1,729
$27.00
-46,683
1
$2.1B
2023-09-02
2023-09-06
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-3,204
$27.00
-86,508
1
$2.1B
2023-09-02
2023-09-06
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-1,247
$27.00
-33,669
1
$2.1B
2023-06-02
2023-06-06
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-1,183
$27.00
-31,941
1
$2.1B
2023-06-02
2023-06-06
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-3,203
$27.00
-86,481
1
$2.1B
2023-06-02
2023-06-06
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-260
$27.00
-7,020
1
$2.1B
2023-03-06
2023-03-09
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Stock Option (right to buy)
42,956
$0.00
1
$2.1B
2023-03-06
2023-03-09
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
26,014
$0.00
1
$2.1B
2023-03-06
2023-03-09
MCGUIRE ANNIE
SVP, General Counsel
A - Grant
Stock Option (right to buy)
38,660
$0.00
1
$2.1B
2023-03-06
2023-03-09
STAPLEY MARC
Chief Executive Officer
A - Grant
Stock Option (right to buy)
129K
$0.00
1
$2.1B
2023-03-06
2023-03-09
WYGANT JONATHAN
VP, Chief Accounting Officer
A - Grant
Stock Option (right to buy)
14,213
$0.00
1
$2.1B
2023-03-06
2023-03-09
WYGANT JONATHAN
VP, Chief Accounting Officer
A - Grant
Common Stock
8,868
$0.00
1
$2.1B
2023-03-02
2023-03-03
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-2,726
$24.00
-65,424
1
$2.1B
2023-03-02
2023-03-03
MCGUIRE ANNIE
SVP, General Counsel
F - Tax
Common Stock
-2,152
$24.00
-51,648
1
$2.1B
2023-03-02
2023-03-03
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-6,029
$24.00
-145K
1
$2.1B
2023-03-02
2023-03-03
WYGANT JONATHAN
VP, Chief Accounting Officer
F - Tax
Common Stock
-1,224
$24.00
-29,376
1
$2.1B
2022-12-06
2022-12-08
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-1,023
$27.00
-27,621
1
$2.1B
2022-12-02
2022-12-06
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-1,008
$29.00
-29,232
1
$2.1B
2022-12-02
2022-12-06
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-2,042
$29.00
-59,218
1
$2.1B
2022-12-02
2022-12-06
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-1,012
$29.00
-29,348
1
$2.1B
2022-12-02
2022-12-06
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-735
$29.00
-21,315
1
$2.1B
2022-12-01
2022-12-05
ANDERSON BONNIE
Executive Chairwoman
M - Exercise
Common Stock
80,000
$11.00
880K
2
$2.1B
2022-12-01
2022-12-05
ANDERSON BONNIE
Executive Chairwoman
M - Exercise
Stock Option (right to buy)
-80,000
$0.00
2
$2.1B
2022-12-01
2022-12-05
ANDERSON BONNIE
Executive Chairwoman
S - Sale
Common Stock
-80,000
$28.00
-2.24M
2
$2.1B
2022-11-11
2022-11-15
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-2
$29.00
-58
1
$2.1B
2022-11-11
2022-11-15
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-2
$0.00
1
$2.1B
2022-11-11
2022-11-15
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
2
$14.00
28
1
$2.1B
2022-11-04
2022-11-08
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-1,023
$25.00
-25,575
1
$2.1B
2022-10-13
2022-10-17
ANDERSON BONNIE
Executive Chairwoman
M - Exercise
Stock Option (right to buy)
-11,088
$0.00
2
$2.1B
2022-10-13
2022-10-17
ANDERSON BONNIE
Executive Chairwoman
M - Exercise
Common Stock
11,088
$9.00
99,792
2
$2.1B
2022-09-02
2022-09-07
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-2,042
$19.00
-38,798
1
$2.1B
2022-09-02
2022-09-07
CHAMBERS REBECCA
Chief Financial Officer
F - Tax
Common Stock
-3,023
$19.00
-57,437
1
$2.1B
2022-09-02
2022-09-07
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-1,008
$19.00
-19,152
1
$2.1B
2022-09-02
2022-09-07
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-1,012
$19.00
-19,228
1
$2.1B
2022-08-08
2022-08-09
ANDERSON BONNIE
Executive Chairwoman
S - Sale
Common Stock
-45,000
$27.00
-1.22M
2
$2.1B
2022-08-05
2022-08-09
WYGANT JONATHAN
VP, Chief Accounting Officer
A - Grant
Common Stock
8,561
$0.00
1
$2.1B
2022-08-05
2022-08-09
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Stock Option (right to buy)
18,248
$0.00
1
$2.1B
2022-08-05
2022-08-09
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Common Stock
10,702
$0.00
1
$2.1B
2022-08-05
2022-08-09
ANDERSON BONNIE
Executive Chairwoman
S - Sale
Common Stock
-76,917
$28.00
-2.15M
1
$2.1B
2022-08-05
2022-08-09
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-1,028
$27.00
-27,756
1
$2.1B
2022-08-05
2022-08-09
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
36,496
$0.00
1
$2.1B
2022-08-05
2022-08-09
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
21,404
$0.00
1
$2.1B
2022-08-05
2022-08-09
MCGUIRE ANNIE
SVP, General Counsel
A - Grant
Stock Option (right to buy)
18,248
$0.00
1
$2.1B
2022-08-05
2022-08-09
WYGANT JONATHAN
VP, Chief Accounting Officer
A - Grant
Stock Option (right to buy)
14,598
$0.00
1
$2.1B
2022-08-05
2022-08-09
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-5
$0.00
3
$2.1B
2022-08-05
2022-08-09
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
5
$8.00
40
3
$2.1B
2022-06-10
2022-06-13
STAPLEY MARC
Chief Executive Officer
P - Purchase
Common Stock
60,000
$16.00
960K
1
$2.1B
2022-06-02
2022-06-06
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-2,042
$18.00
-36,756
1
$2.1B
2022-06-02
2022-06-06
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-1,008
$18.00
-18,144
1
$2.1B
2022-06-02
2022-06-06
STAPLEY MARC
Chief Executive Officer
F - Tax
Common Stock
-4,047
$18.00
-72,846
1
$2.1B
2022-05-01
2022-05-03
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-736
$20.00
-14,720
1
$2.1B
2022-03-04
2022-03-09
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-23,033
$25.00
-576K
3
$2.1B
2022-03-04
2022-03-09
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-4,407
$0.00
1
$2.1B
2022-03-04
2022-03-09
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
4,407
$6.00
26,442
1
$2.1B
2022-03-03
2022-03-09
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Stock Option (right to buy)
77,287
$0.00
1
$2.1B
2022-03-03
2022-03-09
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Common Stock
42,412
$0.00
1
$2.1B
2022-03-04
2022-03-07
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-4,407
$0.00
1
$2.1B
2022-03-04
2022-03-07
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-23,003
$25.00
-575K
3
$2.1B
2022-03-04
2022-03-07
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
4,407
$6.00
26,442
1
$2.1B
2022-03-03
2022-03-07
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Stock Option (right to buy)
77,287
$0.00
1
$2.1B
2022-03-03
2022-03-07
ANDERSON BONNIE
Executive Chairwoman
A - Grant
Stock Option (right to buy)
32,195
$0.00
1
$2.1B
2022-03-03
2022-03-07
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Stock Option (right to buy)
37,773
$0.00
1
$2.1B
2022-03-03
2022-03-07
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
20,728
$0.00
1
$2.1B
2022-03-03
2022-03-07
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Common Stock
42,412
$0.00
1
$2.1B
2022-03-03
2022-03-07
NOVA TINA SUSAN
President, CLIA U.S.
A - Grant
Stock Option (right to buy)
103K
$0.00
1
$2.1B
2022-03-03
2022-03-07
STAPLEY MARC
Chief Executive Officer
A - Grant
Stock Option (right to buy)
103K
$0.00
1
$2.1B
2022-03-02
2022-03-04
NOVA TINA SUSAN
President, CLIA U.S.
F - Tax
Common Stock
-10,695
$28.00
-299K
1
$2.1B
2022-03-02
2022-03-04
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-10,337
$28.00
-289K
1
$2.1B
2022-03-02
2022-03-04
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-4,521
$28.00
-127K
1
$2.1B
2022-02-28
2022-03-02
MCGUIRE ANNIE
SVP, General Counsel
A - Grant
Stock Option (right to buy)
42,175
$0.00
1
$2.1B
2021-12-09
2021-12-10
ANDERSON BONNIE
Executive Chairwoman
M - Exercise
Stock Option (right to buy)
-11,286
$0.00
1
$2.1B
2021-12-09
2021-12-10
ANDERSON BONNIE
Executive Chairwoman
M - Exercise
Common Stock
11,286
$9.00
102K
1
$2.1B
2021-12-07
2021-12-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-6,125
$25.00
-153K
2
$2.1B
2021-12-07
2021-12-08
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-6,125
$40.00
-245K
2
$2.1B
2021-12-07
2021-12-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
6,125
$25.00
153K
2
$2.1B
2021-12-06
2021-12-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
8,156
$13.00
106K
2
$2.1B
2021-12-06
2021-12-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-8,156
$0.00
2
$2.1B
2021-12-06
2021-12-08
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-9,232
$36.00
-332K
3
$2.1B
2021-12-02
2021-12-06
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-2,288
$39.00
-89,232
1
$2.1B
2021-12-02
2021-12-06
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-912
$39.00
-35,568
1
$2.1B
2021-11-01
2021-11-03
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-149
$52.00
-7,748
1
$2.1B
2021-09-17
2021-09-21
ANDERSON BONNIE
Executive Chairwoman
S - Sale
Common Stock
-2,600
$50.00
-130K
1
$2.1B
2021-09-10
2021-09-14
ANDERSON BONNIE
Executive Chairwoman
S - Sale
Common Stock
-1,900
$50.00
-95,000
1
$2.1B
2021-09-08
2021-09-09
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-926
$51.00
-47,226
1
$2.1B
2021-09-07
2021-09-09
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-12,531
$51.00
-639K
2
$2.1B
2021-09-07
2021-09-09
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-12,531
$0.00
3
$2.1B
2021-09-07
2021-09-09
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
12,531
$17.00
213K
3
$2.1B
2021-09-02
2021-09-07
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-2,288
$53.00
-121K
1
$2.1B
2021-09-02
2021-09-07
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-912
$53.00
-48,336
1
$2.1B
2021-07-19
2021-07-20
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Stock Option (right to buy)
67,000
$0.00
1
$2.1B
2021-07-19
2021-07-20
CHAMBERS REBECCA
Chief Financial Officer
A - Grant
Common Stock
34,000
$0.00
1
$2.1B
2021-06-23
2021-06-25
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-4,375
$40.00
-175K
1
$2.1B
2021-06-23
2021-06-25
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-4,375
$0.00
1
$2.1B
2021-06-23
2021-06-25
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
4,375
$25.00
109K
1
$2.1B
2021-06-04
2021-06-08
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-9,081
$35.00
-318K
3
$2.1B
2021-06-04
2021-06-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-8,156
$0.00
2
$2.1B
2021-06-04
2021-06-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
8,156
$13.00
106K
2
$2.1B
2021-06-02
2021-06-04
ANDERSON BONNIE
Executive Chairwoman
F - Tax
Common Stock
-2,288
$36.00
-82,368
1
$2.1B
2021-06-02
2021-06-04
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-912
$36.00
-32,832
1
$2.1B
2021-06-01
2021-06-03
STAPLEY MARC
Chief Executive Officer
A - Grant
Stock Option (right to buy)
138K
$0.00
1
$2.1B
2021-05-17
2021-05-19
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
14,065
$6.00
84,390
1
$2.1B
2021-05-17
2021-05-19
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-14,065
$0.00
1
$2.1B
2021-05-17
2021-05-18
ALLEY BEVERLY JANE
VP, Corporate Controller
A - Grant
Common Stock
5,500
$0.00
1
$2.1B
2021-04-01
2021-04-05
ALLEY BEVERLY JANE
VP, Corporate Controller
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$2.1B
2021-03-04
2021-03-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-30,970
$0.00
4
$2.1B
2021-03-04
2021-03-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
30,970
$19.00
588K
4
$2.1B
2021-03-04
2021-03-08
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-52,015
$49.00
-2.55M
9
$2.1B
2021-03-02
2021-03-04
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-5,995
$62.00
-372K
1
$2.1B
2021-02-26
2021-03-02
ANDERSON BONNIE
Chairman and CEO
A - Grant
Stock Option (right to buy)
40,000
$0.00
1
$2.1B
2021-02-26
2021-03-02
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$2.1B
2021-02-26
2021-03-02
KENNEDY GIULIA
Chief Scientific & Med Officer
A - Grant
Common Stock
12,500
$0.00
1
$2.1B
2021-02-24
2021-02-26
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-10,048
$62.00
-623K
1
$2.1B
2021-01-13
2021-01-15
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-18,541
$0.00
1
$2.1B
2021-01-13
2021-01-15
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
18,541
$6.00
111K
1
$2.1B
2021-01-12
2021-01-13
ANDERSON BONNIE
Chairman and CEO
S - Sale
Common Stock
-20,354
$50.00
-1.02M
3
$2.1B
2021-01-12
2021-01-13
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
20,354
$6.00
122K
1
$2.1B
2021-01-12
2021-01-13
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-20,354
$0.00
1
$2.1B
2021-01-11
2021-01-13
ANDERSON BONNIE
Chairman and CEO
S - Sale
Common Stock
-71,105
$51.00
-3.63M
3
$2.1B
2021-01-11
2021-01-13
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-71,105
$0.00
2
$2.1B
2021-01-11
2021-01-13
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
71,105
$9.00
640K
2
$2.1B
2020-12-29
2020-12-30
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-31,313
$0.00
2
$2.1B
2020-12-29
2020-12-30
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
31,313
$4.00
125K
2
$2.1B
2020-12-04
2020-12-04
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-13,468
$0.00
3
$2.1B
2020-12-04
2020-12-04
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
13,468
$11.00
148K
3
$2.1B
2020-12-04
2020-12-04
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-14,015
$57.00
-799K
3
$2.1B
2020-12-02
2020-12-04
HANNA JOHN WALTER JR
Chief Commercial Officer
F - Tax
Common Stock
-465
$55.00
-25,575
1
$2.1B
2020-12-02
2020-12-04
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-540
$55.00
-29,700
1
$2.1B
2020-11-10
2020-11-12
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
-20,000
$42.00
-840K
4
$2.1B
2020-11-10
2020-11-12
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
20,000
$9.00
180K
1
$2.1B
2020-11-10
2020-11-12
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$2.1B
2020-11-06
2020-11-09
HANNA JOHN WALTER JR
Chief Commercial Officer
S - Sale
Common Stock
-21,250
$43.00
-914K
2
$2.1B
2020-11-06
2020-11-09
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-21,250
$0.00
1
$2.1B
2020-11-06
2020-11-09
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Common Stock
21,250
$20.00
425K
1
$2.1B
2020-11-05
2020-11-06
HANNA JOHN WALTER JR
Chief Commercial Officer
S - Sale
Common Stock
-6,406
$41.00
-263K
3
$2.1B
2020-11-05
2020-11-06
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-6,406
$0.00
2
$2.1B
2020-11-05
2020-11-06
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Common Stock
6,406
$7.00
44,842
2
$2.1B
2020-10-08
2020-10-09
ANDERSON BONNIE
Chairman and CEO
S - Sale
Common Stock
-50,000
$38.00
-1.90M
1
$2.1B
2020-10-08
2020-10-09
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-50,000
$0.00
1
$2.1B
2020-10-08
2020-10-09
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
50,000
$9.00
450K
1
$2.1B
2020-10-06
2020-10-07
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-2,500
$35.00
-87,500
1
$2.1B
2020-10-06
2020-10-07
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-2,500
$0.00
1
$2.1B
2020-10-06
2020-10-07
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
2,500
$20.00
50,000
1
$2.1B
2020-09-10
2020-09-14
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$2.1B
2020-09-10
2020-09-14
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
20,000
$9.00
180K
1
$2.1B
2020-09-04
2020-09-08
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-7,027
$31.00
-218K
3
$2.1B
2020-09-04
2020-09-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-6,479
$0.00
2
$2.1B
2020-09-04
2020-09-08
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
6,479
$8.00
51,832
2
$2.1B
2020-09-02
2020-09-04
KENNEDY GIULIA
Chief Scientific & Med Officer
F - Tax
Common Stock
-540
$34.00
-18,360
1
$2.1B
2020-09-02
2020-09-04
HANNA JOHN WALTER JR
Chief Commercial Officer
F - Tax
Common Stock
-325
$34.00
-11,050
1
$2.1B
2020-08-31
2020-09-01
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-56,443
$0.00
6
$2.1B
2020-08-31
2020-09-01
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Common Stock
56,443
$8.00
452K
6
$2.1B
2020-08-31
2020-09-01
HANNA JOHN WALTER JR
Chief Commercial Officer
S - Sale
Common Stock
-56,443
$33.00
-1.86M
2
$2.1B
2020-08-21
2020-08-25
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Common Stock
1,400
$9.00
12,600
1
$2.1B
2020-08-21
2020-08-25
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-1,400
$0.00
1
$2.1B
2020-08-21
2020-08-25
HANNA JOHN WALTER JR
Chief Commercial Officer
S - Sale
Common Stock
-1,400
$36.00
-50,400
1
$2.1B
2020-08-10
2020-08-12
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$2.1B
2020-08-10
2020-08-12
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
-20,000
$32.00
-640K
1
$2.1B
2020-08-10
2020-08-12
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
20,000
$9.00
180K
1
$2.1B
2020-07-31
2020-08-04
HANNA JOHN WALTER JR
Chief Commercial Officer
S - Sale
Common Stock
-14,095
$36.00
-507K
1
$2.1B
2020-07-31
2020-08-04
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-20,000
$35.00
-700K
1
$2.1B
2020-07-31
2020-08-04
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-14,095
$0.00
1
$2.1B
2020-07-31
2020-08-04
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Common Stock
14,095
$9.00
127K
1
$2.1B
2020-07-31
2020-08-04
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-20,000
$0.00
1
$2.1B
2020-07-31
2020-08-04
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
20,000
$20.00
400K
1
$2.1B
2020-07-30
2020-07-31
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-11,365
$0.00
1
$2.1B
2020-07-30
2020-07-31
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
11,365
$9.00
102K
1
$2.1B
2020-07-23
2020-07-27
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
3,280
$9.00
29,520
1
$2.1B
2020-07-23
2020-07-27
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-3,280
$0.00
1
$2.1B
2020-07-22
2020-07-27
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-100
$0.00
1
$2.1B
2020-07-21
2020-07-27
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
3,447
$9.00
31,023
1
$2.1B
2020-07-21
2020-07-27
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-3,447
$0.00
1
$2.1B
2020-07-20
2020-07-27
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
20,349
$8.00
163K
2
$2.1B
2020-07-20
2020-07-27
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-20,349
$0.00
2
$2.1B
2020-07-22
2020-07-22
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-100
$0.00
1
$2.1B
2020-07-21
2020-07-22
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-653
$0.00
1
$2.1B
2020-07-21
2020-07-22
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Common Stock
653
$2.00
1,306
1
$2.1B
2020-07-21
2020-07-22
HANNA JOHN WALTER JR
Chief Commercial Officer
S - Sale
Common Stock
-653
$32.00
-20,896
1
$2.1B
2020-07-21
2020-07-22
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-3,447
$0.00
1
$2.1B
2020-07-21
2020-07-22
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
3,447
$9.00
31,023
1
$2.1B
2020-07-20
2020-07-22
HANNA JOHN WALTER JR
Chief Commercial Officer
S - Sale
Common Stock
-11,294
$32.00
-361K
1
$2.1B
2020-07-20
2020-07-22
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Stock Option (right to buy)
-11,294
$0.00
1
$2.1B
2020-07-20
2020-07-22
HANNA JOHN WALTER JR
Chief Commercial Officer
M - Exercise
Common Stock
11,294
$2.00
22,588
1
$2.1B
2020-07-20
2020-07-22
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Common Stock
20,349
$8.00
163K
2
$2.1B
2020-07-20
2020-07-22
ANDERSON BONNIE
Chairman and CEO
M - Exercise
Stock Option (right to buy)
-20,349
$0.00
2
$2.1B
2020-07-13
2020-07-14
KENNEDY GIULIA
Chief Scientific & Med Officer
S - Sale
Common Stock
-16,738
$30.00
-502K
3
$2.1B
2020-07-13
2020-07-14
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Stock Option (right to buy)
-16,738
$0.00
3
$2.1B
2020-07-13
2020-07-14
KENNEDY GIULIA
Chief Scientific & Med Officer
M - Exercise
Common Stock
16,738
$13.00
218K
3
$2.1B
2020-07-06
2020-07-07
KENNEDY KEITH
COO / CFO
M - Exercise
Stock Option (right to buy)
-47,658
$0.00
3
$2.1B